OakChart

Quantum BioPharma Ltd

QNTMHealthcare·Biotechnology·Canada·Nano·NASD·Nov 11 • 3:59 PM ET

1.94-0.08 (-3.96%)
2026-11-12 04:04 CET
Market cap
15.69 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-25.16 USD m
Free cash flow, TTM
-5.38 USD m
EPS diluted, TTM
-5.69
P/E
-
Compare

Price

QNTM against its 20, 50 and 200-day averages
2050200earnings
2.004.006.008.0010.00913K1.8MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26QNTMclose 1.9420-day 2.2950-day 2.95200-day 3.711.94

84.4% under the 52-week high of 12.42 on 28 Nov 2025. 52-week low 1.91 on 11 Nov 2026. Last 15 sessions, 30.9% high to low

Volume 0.83× normal · the line is the 50-bar volume average

Profile

QNTM
52-week range, 0% of the way up
2.0012.42

Quantum BioPharma Ltd. is a biopharmaceutical company, which engages in building a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory, metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. It operates through the Biopharmaceutical and Strategic Investments segments. The Biopharmaceutical segment focuses on furthering the research and development of the drug candidates and the development of a treatment for alcohol misuse for application in hospitals and other medical practices. The Strategic Investments segment is involved in the generation of returns and cash flow through the issuance of loans secured by residential property, with FSD Strategic Investments having a first or second collateral mortgage on the secured property. The company was founded by Thomas Fairfull, Zeeshan Saeed, and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

Employees7
IPOJun 08, 2018
Beta0.50
ATR, 14d0.20
Rel volume0.83
Short float6.26%
Insider own13.05%
Inst own7.19%

Snapshot

6 groups

Valuation

Index-
Market Cap15.69M
Enterprise Value5.04M
Income-25.16M
Sales0.00M
Book/sh1.05
Cash/sh1.21
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees7
IPOJun 08, 2018

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B1.85
P/C1.61
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio1.19
Current Ratio1.20
Debt/Eq0.12
LT Debt/Eq0.00
Option/ShortNo / Yes

Earnings

EPS (ttm)-5.69
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y-135.55% -24.71%
Sales past 3/5Y- -
EPS Y/Y TTM56.35%
Sales Y/Y TTM-
EPS Q/Q84.03%
Sales Q/Q-
EarningsAug 13 AMC
EPS/Sales Surpr.- -

Ownership

Insider Own13.05%
Insider Trans0.00%
Inst Own7.19%
Inst Trans4.75%
ROA-169.48%
ROE-429.58%
ROIC-316.49%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA20-15.16%
SMA50-34.25%
SMA200-47.75%
Trades-

Technical

Shs Outstand7.58M
Shs Float7.03M
Short Float6.26%
Short Ratio2.46
Short Interest0.44M
52W High12.42 -84.38%
52W Low2.00 -3.00%
Volatility10.02% 7.71%
ATR (14)0.20
RSI (14)28.19
Beta0.50
Rel Volume0.83
Avg Volume178.83K
Volume147,674

Performance

Perf Week-12.22%
Perf Month-32.87%
Perf Quarter-39.94%
Perf Half Y-64.53%
Perf YTD-73.42%
Perf Year-77.48%
Perf 3Y-97.10%
Perf 5Y-98.00%
Perf 10Y-
Recom1.00
Target Price8.00
Prev Close2.02
Price1.94
Change %-3.96%

Analyst ratings

latest 1 of 1
DateActionAnalystRating changeTargetImplied
Aug 31, 2026InitiatedRRodman & RenshawBuy$8+312.4%

Peers

Mkt cap
TickerCompanyMkt cap
IMUXImmunic Inc110.79M
CLNNClene Inc60.40M
TLSATiziana Life Sciences Ltd79.68M
AZRAzora Therapeutics Inc49.99M
NGENNervGen Pharma Corp145.28M
CMNDClearmind Medicine Inc2.51M
PBMPsyence Biomedical Ltd12.13M
MSLESatellos Bioscience Inc143.23M
ATHEAlterity Therapeutics Ltd ADR44.12M
DRUGBright Minds Biosciences Inc231.32M

Held by

AUM
TickerCompanyAUM
PSILAdvisorShares Psychedelics ETFAUM: 43.26M

News

latest 14 of 99

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-08-13-0.470--0.00--
2026Q12026-05-06-3.060-0.490-3.0210.000.001
2025Q42026-03-26-0.190-1.000-0.7790.000.001
2025Q32025-11-07-1.250-2.690-1.3990.000.901
2025Q22025-08-07-3.230-0.170-3.0630.002.891
2025Q12025-05-14-3.530-0.650-3.4652.172.171
2024Q42025-03-28-2.890-0.800-2.3310.000.951
2024Q32024-11-13-2.780-2.780-4.1700.000.001
2024Q22024-08-09-0.080-3.900-0.0750.000.001
2024Q12024-05-16-3.250-3.250-0.0480.000.001
2023Q42024-03-28-2.600-9.055-0.042-0.001
2023Q32023-11-15-1.937-9.055-0.0290.000.001
2021Q32021-11-15-9.750--0.160---
2021Q22021-08-12-22.750--0.367---
2019Q32019-11-29-1.656--0.0080.01--
2026Q3---0.500--0.001

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY-152.59-261.31-2.64014.510.00
2021FY-62.719--1.010--
2023FY-29.900--0.4610.00-
2024FY-13.120-3.270-12.4920.000.95
2025FY-8.200-8.110-0.000.00
2026FY--1.850--0.00

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-05-071000.000.000.00
2026Q3S2026-03-301000.000.000.00
2026Q3S2026-01-241000.000.000.00
2026Q3S2025-11-111010.000.000.00
2026Q3S2025-11-101010.000.000.00
2026Q3S2025-11-091002.602.602.60
2026Q3S2025-11-081002.602.602.60
2026Q3S2025-11-071002.602.602.60
2026Q3S2025-11-061002.602.602.60
2026Q3S2025-11-051002.602.602.60
2026Q3S2025-11-041002.602.602.60
2026Q3S2025-11-031002.602.602.60
2026Q3S2025-11-021002.602.602.60
2026Q3S2025-11-011002.602.602.60

Estimate history

EPS, annual-0.003-0.015-5.545-2.64-1.01-0.61-0.461-12.492-7.966-5.6874
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.075-4.17-2.331-3.465-3.063-1.399-0.779-3.021-0.489
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual0000000000
Period201720182019202020212022202320242025TTM
Sales, quarterly000000000
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual1319.61375.67.90619.16240.45138.50439.3772.33.8887.577
Period201720182019202020212022202320242025MRQ
Shares, quarterly47.4081.8642.32.7113.4693.8173.8885.8567.577
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue0.000.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.530.550.492.514.544.053.901.940.14
Gross Profit-0.53-0.55-0.49-2.51-4.54-4.05-3.90-1.94-0.14
Selling, General and Administrative Excl. Other11.7014.7715.3917.0621.5729.5526.1320.4913.26
Research and Development1.582.766.083.866.916.337.830.00-
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-12.23-15.32-15.88-19.57-26.11-33.60-30.03-22.43-13.40
Interest Expense0.460.620.050.000.050.070.240.160.00
Unusual Expense13.3413.87-0.69-0.22-0.410.13-1.6211.534.19
Net Income Before Taxes-25.30-26.96-14.92-18.23-26.70-33.94-28.45-34.08-17.52
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-25.30-26.96-14.92-18.23-26.70-33.94-28.45-34.08-17.52
Net Income From Continuing Operations-25.16-26.18-14.20-18.23-26.70-33.94-28.45-34.08-17.52
Net Income-25.16-26.18-14.20-18.23-23.61-35.29-31.80-39.13-17.52
EPS (Recurring)-2.38-5.01-12.92-0.46-0.62-1.01-2.73-4.40-0.01
EPS (Basic, Before Extraordinaries)-5.69-7.97-12.49-0.46-0.61-1.01-2.64-5.55-0.01
EPS (Diluted)-5.69-7.97-12.49-0.46-0.61-1.01-2.64-5.55-0.01
EBITDA-11.70-14.77-15.39-17.06-21.57-29.55-26.13-20.49-13.26
Non-Operating Income (Expense)0.742.850.321.12-0.96-0.150.190.040.07
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.712.950.153.841.537.448.0512.084.97
Price To Sales Ratio-------197.70-
Shares Outstanding7.583.892.3039.3838.5040.4519.167.911,375.60
Market Capitalization15.6915.697.062,353.141,953.202,681.891,942.992,789.613,844,255.71

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.130.130.130.150.140.130.110.12
Gross Profit-0.13-0.13-0.13-0.15-0.14-0.13-0.11-0.12
Selling, General and Administrative Excl. Other2.182.782.234.514.653.265.973.95
Research and Development0.390.630.070.500.551.654.280.74
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-2.31-2.91-2.36-4.66-4.79-3.39-6.09-4.07
Interest Expense0.240.050.070.110.240.350.020.01
Unusual Expense0.5910.761.540.466.745.13-0.67-0.01
Net Income Before Taxes-3.09-13.75-3.70-4.75-9.77-8.74-5.46-4.02
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-3.09-13.75-3.70-4.75-9.77-8.74-5.46-4.02
Net Income From Continuing Operations-3.25-13.56-3.03-5.32-9.25-8.58-5.36-3.83
Net Income-3.25-13.56-3.03-5.32-9.25-8.58-5.36-3.83
EPS (Recurring)-0.43-1.34-0.50-1.32-1.50-2.01-2.53-4.18
EPS (Basic, Before Extraordinaries)-0.49-3.02-0.78-1.40-3.06-3.47-2.33-4.17
EPS (Diluted)-0.49-3.02-0.78-1.40-3.06-3.47-2.33-4.17
EBITDA-2.18-2.78-2.23-4.51-4.65-3.26-5.97-3.95
Non-Operating Income (Expense)0.04-0.040.270.472.000.13-0.020.06
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.010.890.811.000.850.29-0.080.07
Shares Outstanding7.585.863.893.823.472.712.301.86
Market Capitalization15.6919.8928.0544.4654.9014.807.067.43

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments6.188.063.5116.9835.4217.525.9715.473.85
Short Term Receivables0.233.817.420.400.500.161.560.720.25
Inventories0.050.120.000.000.000.000.710.000.00
Other Current Assets0.020.070.160.4710.019.180.320.330.20
Total Current Assets6.4812.0511.0917.8545.9326.878.5616.534.30
Net Property, Plant & Equipment0.170.130.120.260.170.008.988.896.62
Total Investments and Advances0.000.000.010.830.661.688.8613.230.00
Long-Term Note Receivable-0.000.917.43-----
Intangible Assets4.514.935.3612.0416.2013.4216.820.000.00
Other Assets0.000.000.000.000.000.000.000.000.00
Total Assets11.1617.1217.4738.4162.9641.9743.2238.6410.92
Short Term Debt Incl. Current Port. of LT Debt1.880.820.340.480.420.431.480.000.00
Accounts Payable0.000.000.000.003.003.703.360.000.00
Other Current Liabilities4.185.854.237.355.281.451.991.281.01
Total Current Liabilities6.066.684.577.838.705.586.831.281.01
Long Term Debt0.000.000.000.040.130.080.110.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.000.000.000.00
Total Liabilities6.066.684.577.878.835.666.941.281.01
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity6.9211.4813.2430.5454.1336.3136.2837.369.91
Total Shareholders Equity6.9211.4813.2430.5454.1336.3136.2837.369.91
Accumulated Minority Interest-1.82-1.04-0.330.000.000.000.000.000.00
Total Equity5.1010.4412.9130.5454.1336.3136.2837.369.91
Total Liabilities & Stockholders Equity11.1617.1217.4738.4162.9641.9743.2238.6410.92
Book Value Per Share1.784.990.340.791.341.894.590.030.01
Tangible Book Value Per Share0.622.850.200.480.941.192.460.030.01
Full-Time Employees77--102023--
Price to Book Ratio1.850.42158.6154.0449.5453.5175.02102,894.0972,895.89
Return on Assets-185.11-82.11-65.24-52.68-64.69-65.96-83.27-70.71-47.45
Return on Equity-284.44-114.92-83.28-63.07-75.05-77.43-92.56-74.13-53.12
Return on Invested Capital-378.01-123.71-137.73-77.20-65.03-87.39-107.53-46.89-27.41
Quick Ratio1.061.792.432.285.284.821.1512.944.26
Current Ratio1.071.802.432.285.284.821.2512.944.26

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-24.95-26.96-14.92-18.23-26.70-33.94-28.45-34.08-17.52
Depreciation0.530.550.492.514.534.053.901.940.14
Other Funds (Non Cash)15.0016.19-2.213.260.966.264.6117.323.37
Funds from Operations-9.43-10.22-16.63-12.47-21.21-23.63-19.94-14.82-14.01
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital4.051.999.761.64-7.122.890.811.10-0.25
Cash from Operating Activities-5.38-8.24-6.88-10.83-28.33-20.75-19.13-13.71-14.27
Capital Expenditures0.000.000.000.00-0.36-0.500.00-0.29-3.11
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.770.000.001.58
Purchase or Sale of Investments-3.44-1.95-1.50-0.30-0.240.006.480.46-6.17
Purchase of Investments-6.10-6.09-7.69-0.74-0.400.000.000.00-6.17
Sale Or Maturity of Investments2.674.146.190.440.160.006.480.460.00
Other Uses0.000.000.000.000.000.000.00-0.400.00
Other Sources0.000.000.000.0312.730.000.040.000.00
Cash from Investing Activities-3.44-1.95-1.50-0.2712.120.276.51-0.23-7.71
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock8.180.5310.67-2.94-1.9338.3425.164.0534.62
Repurchase of Common Pref Stock0.000.000.00-2.96-1.930.000.000.000.00
Sale of Common Pref Stock8.180.5310.670.020.0038.3425.164.0534.62
Proceedsfrom Stock Options8.180.3410.670.000.0038.3425.103.4331.80
Issuance or Reduction of Debt, Net1.935.361.010.000.00-0.07-0.950.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow1.020.330.000.000.000.000.000.000.00
Other Financing Activities Uses-0.81-1.500.000.000.000.000.000.000.00
Cash from Financing Activities11.026.1011.62-3.13-2.0738.2124.174.0134.62
Net Change in Cash2.21-4.093.24-14.22-18.2817.7311.56-9.9312.65
Free Cash Flow-5.38-8.24-6.88-10.83-28.45-20.75-19.13-13.71-17.38
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments9.7510.036.186.296.586.28
Short Term Receivables0.110.210.232.943.233.41
Inventories0.050.050.050.080.080.09
Other Current Assets0.060.080.020.040.450.14
Total Current Assets9.9610.376.489.3410.349.93
Net Property, Plant & Equipment0.130.150.170.190.230.11
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets4.304.414.514.624.734.83
Other Assets0.000.000.000.000.000.00
Total Assets14.3914.9311.1614.1515.3014.87
Short Term Debt Incl. Current Port. of LT Debt0.960.871.882.562.271.28
Accounts Payable0.000.000.000.000.000.00
Other Current Liabilities7.3315.484.184.0910.989.06
Total Current Liabilities8.3016.356.066.6513.2510.34
Long Term Debt0.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities8.3016.356.066.6513.2510.34
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity7.950.606.928.653.765.73
Total Shareholders Equity7.950.606.928.653.765.73
Accumulated Minority Interest-1.86-2.02-1.82-1.15-1.72-1.20
Total Equity6.09-1.425.107.512.054.53
Total Liabilities & Stockholders Equity14.3914.9311.1614.1515.3014.87
Book Value Per Share1.050.101.782.271.092.11
Tangible Book Value Per Share0.48-0.650.621.06-0.280.33
Full-Time Employees--7---
Price to Book Ratio1.852.713.227.769.581.54
Return on Assets-169.48-209.12-185.11-171.84-176.91-137.74
Return on Equity-429.58-984.82-284.44-228.60-367.03-235.05
Return on Invested Capital-40.92-2,278.18-43.71-61.48-245.85-149.61
Quick Ratio1.190.631.061.390.770.95
Current Ratio1.200.631.071.410.780.96

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-3.01-13.75-3.40-4.78-10.09-8.74
Depreciation0.130.130.120.150.150.13
Other Funds (Non Cash)-3.4315.262.440.738.984.07
Funds from Operations-6.321.63-0.84-3.90-0.96-4.55
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital4.55-3.300.642.17-1.100.28
Cash from Operating Activities-1.77-1.67-0.20-1.73-2.06-4.26
Capital Expenditures0.000.000.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-1.34-2.890.380.42-1.41-1.35
Purchase of Investments-1.36-2.96-0.43-1.36-1.52-2.80
Sale Or Maturity of Investments0.010.070.811.780.111.45
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-1.34-2.890.380.42-1.41-1.35
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock2.445.400.34-0.000.150.05
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock2.445.400.34-0.000.150.05
Proceedsfrom Stock Options2.445.400.340.000.000.00
Issuance or Reduction of Debt, Net-0.011.73-0.060.262.053.11
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.00-0.111.13-0.00-0.800.00
Other Financing Activities Uses0.00-0.11-0.70-0.00-0.800.00
Cash from Financing Activities2.427.001.360.261.373.13
Net Change in Cash-0.702.441.54-1.06-2.10-2.48
Free Cash Flow-1.77-1.67-0.20-1.73-2.06-4.26

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-306.26%0.4M7.0M209.60K
2026-10-157.40%0.5M7.0M208.43K
2026-09-305.14%0.4M7.0M195.82K
2026-09-153.45%0.2M7.0M185.20K
2026-08-313.70%0.3M7.1M217.30K
2026-08-144.04%0.3M7.2M272.75K
2026-07-315.34%0.3M5.7M256.19K
2026-07-155.96%0.3M5.7M348.21K
2026-06-306.30%0.4M5.7M388.68K
2026-06-156.10%0.3M5.7M496.60K
2026-05-297.23%0.4M5.7M520.04K
2026-05-154.27%0.2M5.2M434.69K
2026-04-305.83%0.3M4.9M407.01K
2026-04-153.73%0.2M4.9M317.88K
2026-03-317.17%0.2M3.5M271.64K
2026-03-136.62%0.2M3.5M137.51K
2026-02-272.41%0.1M3.5M79.84K
2026-02-133.13%0.1M3.5M106.36K
2026-01-302.37%0.1M3.2M104.04K
2026-01-151.70%0.0M2.8M103.51K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-056-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-05SEC
2026-10-086-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-08SEC
2026-10-066-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-06SEC
2026-10-05SCHEDULE 13G/ASEC
2026-09-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-24SEC
2026-09-176-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-17SEC
2026-09-176-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-17SEC
2026-09-156-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-15SEC
2026-09-086-K/A2026-09-08SEC
2026-09-086-K/A2026-09-08SEC
2026-09-086-K/A2026-09-08SEC
2026-09-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-01SEC
2026-08-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-14SEC
2026-08-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-30SEC
2026-08-136-K/A2026-08-13SEC
2026-08-106-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-10SEC
2026-07-08SCHEDULE 13GSEC
2026-06-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-02SEC
2026-06-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-02SEC
2026-05-186-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-18SEC
2026-05-076-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-07SEC
2026-05-066-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-31SEC
2026-04-226-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-22SEC
2026-04-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-02SEC
2026-04-016-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-01SEC
2026-03-306-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-30SEC
2026-03-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-27SEC
2026-03-2620-FRegistration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer.2025-12-31SEC
2026-03-266-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-26SEC
2026-03-236-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-23SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
AdvisorShares Investments LLC4.95%
JANE STREET GROUP, LLC0.76%
Platform Technology Partners0.51%
Steward Partners Investment Advisory, LLC0.44%
CITADEL ADVISORS LLC0.25%
Marex Group Ltd0.21%
Mariner, LLC0.16%
OSAIC HOLDINGS, INC.0.10%
LANARK FINANCIAL, INC.0.09%
CITIGROUP INC0.07%

Funds

Fund% owned
AdvisorShares Psychedelics ETF3.18%
Blackstone Alternative Multi-Strategy Fund-0.01%

OakChart. QNTM. Cached 15 minutes.

Some panels did not load: insider.